US$ 28.14
american diabetes association 'history of pancreatitis' glp-1 receptor agonist The Use Glucagon-like Peptide-1 Agonists in Patients with Type 2 Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study american diabetes association pancreatitis history
Description
KAM research found that an astounding 7% of UK adults are currently using GLP-1 drugs for weight loss
Dont give up, guys

But the arrival of a new class of appetite-suppressing drugs such as Ozempic and Wegovy has transformed obesity treatment into the most scientifically exciting and commercially lucrative area of healthcare

However, they may not always capture the full range of patient experiences

Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study
